Earnings History for 9/4/2012
|
Earnings Before the Market Opens
| Company | Symbol | Qtr | EPS | Cons. | Surprise | % Beat | Revs | Cons. | Gd. | % Since | % Week | Details |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
CPB | Q412 | $0.41 | $0.38 | +$0.03 | +7.9% | $1.61B | $1.6B | ![]() |
-33.8% | -1.2% | Details |
| Durata Therap | DRTX | Q212 | -$183.31 | N/A | N/A | N/A | N/A | N/A | N/A | +181.9% | +8.9% | Details |
|
|
NTWK | Q412 | $0.25 | $0.14 | +$0.11 | +78.6% | $14.3M | $11.73M | = | -10% | +15.2% | Details |
|
|
NX | Q312 | $0.04 | $0.22 | -$0.18 | -81.8% | $237.9M | $249.84M | N/A | +22.8% | +2.7% | Details |
|
|
SFD | Q113 | $0.40 | $0.45 | -$0.05 | -11.1% | $3.09M | $3.15M | N/A | +16.7% | +6.9% | Details |
Earnings After the Market Close
| Company | Symbol | Qtr | EPS | Cons. | Surprise | % Beat | Revs | Cons. | Gd. | % Since | % Week | Details |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
BLMN | Q212 | $0.18 | N/A | N/A | N/A | $980.87M | $955.5M | = | -19.2% | +7.4% | Details |
|
|
FNSR | Q113 | $0.12 | $0.14 | -$0.02 | -14.3% | $220M | $226.28M | ![]() |
+74.9% | +12.4% | Details |
|
|
FCE-A | Q212 | $0.11 | N/A | N/A | N/A | $261.4M | $244.7M | N/A | +68.4% | +4.9% | Details |
|
|
FRAN | Q212 | $0.28 | $0.24 | +$0.04 | +16.7% | $76.37M | $71.09M | ![]() |
-93.8% | -19.2% | Details |
|
|
GWRE | Q412 | $0.10 | $0.04 | +$0.06 | +150.0% | $67.6M | $62.33M | N/A | +531.1% | +5.3% | Details |
|
|
PBY | Q212 | $0.10 | $0.16 | -$0.06 | -37.5% | $525.7M | $528.27M | N/A | +178.1% | +10.3% | Details |
|
|
PDEX | Q412 | -$0.14 | N/A | N/A | N/A | $17.26M | $24.06M | N/A | +3123.8% | -18.6% | Details |
|
|
SWS | Q412 | -$0.01 | N/A | N/A | N/A | $72.5M | $76.2M | N/A | +16.3% | +5.2% | Details |
|
|
TBAC | Q412 | -$0.33 | N/A | N/A | N/A | $21.6M | $23.2M | N/A | -92.1% | +11.4% | Details |
|
|
TEA | Q212 | -$0.01 | $0.02 | -$0.03 | -150.0% | $43.08M | $40.5M | = | +32.8% | +9.4% | Details |



